FDA grant supports collaborative projects to advance drug development, manufacturing, and regulatory science, focusing on safety, efficacy, and innovation.
NIH will soon offer funding for small businesses with recent SBIR/STTR Phase II/IIB awards to support technical assistance and late-stage R&D for commercialization, excluding clinical trials.
PCORI's Implementation Awards -- Cycle 1 2027 funds projects to put patient-centered CER results into practice, spread evidence, and plan for future implementation in real-world healthcare.
This grant supports investigator-initiated, milestone-driven clinical trials in allergy and infectious diseases, funding trial implementation, training, data management, and related research activities.
This grant supports centers at institutions with strong existing research in NIDDK-related diseases, funding shared resources, collaboration, mentoring, and pilot programs to advance research in areas like diabetes, obesity, and liver diseases.